Talking Biotech: TALEN gene editing to make more nutritious food crops

Gene editing has been the center of attention, affecting everything from plants, to mushrooms, to livestock, to human medicine. However, when we discuss gene editing we typically describe the CRISPR Cas9 system. Such tools have grabbed recent limelight. But churning in the background, the other gene editing methods have been making progress for for years, and products are moving rapidly through pipelines toward approval. Such products will soon be available from Calyxt Corporation. Calyxt Chief Science Officer Dan Voytas discusses how TALEN, a custom sequence-specific nuclease, functions in gene editing. He contrasts it with the Cas9 system and then describes the company pipeline, with products soon to be on the market. He also discusses regulation of the products derived from TALEN technology.

Related article:  FOIA emails reveal anti-GMO, pro-organic spin 'A team' led by Tom Philpott and Michael Pollan

Calyxt website and pipeline here.

Visit Kevin Folta’s Talking Biotech

Follow Talking Biotech on Twitter @TalkingBiotech

Follow Kevin Folta on Twitter @kevinfolta | Facebook: | Lab website: | All funding:

Stitcher | iTunes | Player FM | TuneIn


News on human & agricultural genetics and biotechnology delivered to your inbox.

Send this to a friend